Flowtech Fluidpower's "bought" growth is mostly organic — and it's finally paying down debt

Flowtech Fluidpower reported first-half revenue of £70.4 million, up 23.7%, and the finance world automatically gravitates to one word: acquisitions. When a serial acquirer grows the top line, the easy read is a red flag — bought revenue, paid for with borrowed money, dressed up to look like momentum. This is a company that spent years stitching together a portfolio of hydraulic, pneumatic, and lubrication distributors, so the suspicion is earned.

The cash-flow read says that instinct is only half right. Strip the deals out and like-for-like revenue rose 13.2% in the first half — so organic growth was the larger half of the 23.7% increase, with the acquisitions contributing roughly ten points of it. That is not the profile of a company coasting on deals; it is a distributor whose everyday business is growing at a double-digit clip on its own.

There is history behind why a 24% revenue print earns suspicion rather than applause. Flowtech is a buy-and-build story that went wrong the first time: it levered up to assemble a UK and Benelux network, the shares subsequently collapsed as the balance sheet strained, and holders were burned. So the fair question is not whether revenue is growing — it is whether that growth converts into cash and reduces leverage, or whether management is simply recycling debt into a bigger-looking top line.

On that test, the H1 2026 numbers point the right way. Pre-IFRS 16 net debt — bank debt excluding lease liabilities — fell to £16.5 million at 30 June 2026 from £18.5 million a year earlier. That decline happened even while the company kept acquiring, buying Q Plus in February and Helipebs in June. Paying down debt while still funding deals is exactly the signal a cash-flow buyer wants to see: the engine is generating enough to feed both itself and the lenders.

Profitability supports it. Adjusted EBITDA for the half came in at £4.5 million, against £3.5 million in H1 2025. And it follows a 2025 in which EBITDA rose more than 30% from the prior year's £5.9 million. The direction of travel across both years is expansion, not a single favorable quarter.

Leverage and the margin of safety

Now the survival arithmetic that gates the buy-versus-pass decision. Net debt of £16.5 million against the roughly £10.2 million of underlying EBITDA the market expects for full-year 2026 works out to leverage of about 1.6 times. That is comfortable for a stable industrial distributor and a long way from the strained balance sheet that defined the company's earlier problems. There is £8.5 million of headroom left in a £25 million facility that runs to 2029. The survival risk that once dominated the story has, on current numbers, largely been removed.

The valuation reflects the lingering doubt rather than the improving data. The shares trade near 68 pence for a market capitalization of about £55 million; add the net debt and enterprise value sits near £71 million, which against that forward EBITDA figure is roughly 7 times. That is not a deep-value scream for a small-cap distributor, but it is not expensive either — and the direction of the multiple is what matters. Consensus has net debt falling to £11.3 million by year-end, so even as the business grows, leverage keeps coming down. A business that is growing double-digit, converting to cash, and deleveraging is the kind of setup where a modest multiple can re-rate rather than compress.

What would change the read

The discipline here is to name the condition that separates a working turnaround from another trap. For Flowtech, that condition is margin and the timing of cash. Gross margin declined during the half, with management explicitly flagging inflation and supply-chain pressures tied to the Middle East conflict. For a distributor, gross margin is the whole ballgame — there is no product magic to lean on, only buy-and-sell spread and volume. If margin keeps eroding as the company pushes the acquired businesses harder, growth in EBITDA could outrun its own quality.

The second condition is the shape of cash flow in the back half. Management expects strong H2 generation, but part of that rests on inflows from two major bridge infrastructure projects that slipped out of the first half and on a seasonal unwind of working capital — timing dependencies, not guarantees. And of roughly £30 million of annualized revenue the five recent acquisitions bring in, only about £3 million arrives as EBITDA — a thin margin on the acquired base that still has to prove it can be lifted toward the group's standard.

None of that undermines the central finding. The headline invites the reader to file Flowtech under "bought growth, beware the serial acquirer." The evidence says the growth is mostly organic, it is converting into cash, and it is paying for the debt rather than adding to it — the buy-and-build engine appears to be fueling itself for the first time in years. Margin and the H2 cash delivery are the unresolved variables: if they hold, the modest multiple looks like room to run; if gross margin keeps slipping, the EBITDA growth gets less impressive fast. That is the tension the next six months resolve.